Ten years of liver transplantation: An evolving understanding of late graft loss

Transplantation

Volumn 64, Issue 12, 1997, Pages 1801-1807

  Abbasoglu, Osman ^a   Levy, Marlon F ^a   Brkic, Borisa B ^a   Testa, Giuliano ^a   Rohan Jeyarajah, D ^a   Goldstein, Robert M ^a   Husberg, Bo ^a   Gonwa, Thomas A ^a   Klintmalm, Goran B ^a  

^a BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; BILE DUCT OBSTRUCTION; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; COMORBIDITY; CONFERENCE PAPER; DISEASE ASSOCIATION; FEMALE; GRAFT REJECTION; HUMAN; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; RISK FACTOR; SEPSIS; SURVIVAL RATE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; CARDIOVASCULAR DISEASES; CEREBROVASCULAR DISORDERS; COMMUNICABLE DISEASES; FEMALE; GRAFT SURVIVAL; HUMANS; LIVER DISEASES; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 0031434853     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199712270-00030     Document Type: Conference Paper

References (45)

1. Busuttil RW, Shaked A, Millis JM, et al. One thousand liver transplants: the lessons learned. Ann Surg 1994; 219: 490.
2. Mora NP, Klintmalm GB, Solomon H, et al. Survival after liver transplantation in 300 consecutive patients: the influence of age, clinical status, and pretransplant disease. Transplant Proc 1992; 24: 156.
3. Eid A, Steffen R, Sterioff S, et al. Long-term outcome after liver transplantation. Transplant Proc 1989; 21: 2409.
4. Levy MF, Goldstein RM, Husberg BS. Baylor update: outcome analysis in liver transplantation. In: Terasaki P, Cecka JM, eds. Clinical Transplants 1993. Los Angeles: UCLA Tissue Typing Laboratory, 1993: 161.
5. Goldstein RM, Olson LM, Klintmalm GB, et al. Decreased mortality associated with orthotopic liver transplantation. Transplant Proc 1988; 20(suppl 1): 610.
6. Abbasoglu O, Levy M, Vodapally MS, et al. Hepatic artery stenosis after liver transplantation: incidence, presentation, treatment, and long-term outcome. Transplantation 1997; 63: 250.
7. Dousset B, Houssin D. Liver transplantation: the challenges of the 1990s. Biomed Pharmacother 1992; 46: 79.
8. Levy M, Jennings L, Abouljoud MS, et al. Quality of life improvements at one, two, and five years posttransplantation. Transplantation 1995; 59: 515.
9. Backman L, Gibbs J, Levy M, et al. Causes of late graft loss after liver transplantation. Transplantation 1993; 55: 1078.
10. Asfar S, Metrakos P, Fryer J, et al. An analysis of late deaths after liver transplantation. Transplantation 1996; 61: 1377.
11. Iwatsuki S, Starzl TE, Gordon RD, et al. Late mortality and morbidity after liver transplantation. Transplant Proc 1987; 19: 2373.
12. Shaw BW, Wood RP, Stratta RJ, et al. Stratifying the causes of death in liver transplant recipients. Arch Surg 1989; 124: 895.
13. Konig V, Hopf U, Neuhaus P, et al. Long-term follow-up of hepatitis B virus-infected recipients after orthotopic liver transplantation. Transplantation 1994; 58: 553.
14. McGory RW, Ishitani MB, Oliveira WM, et al. Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization. Transplantation 1996; 61: 1358.
15. Lemmens HP, Langrehr JM, Blumhardt G, et al. Outcome following orthotopic liver transplantation in HBsAg-positive patients using short- or long-term immunoprophylaxis. Transplant Proc 1994; 26: 3622.
16. Holt CD, Millis JM, Busuttil RW. Role of liver transplantation in patients with hepatitis B infection. Clin Transplant 1995; 9: 269.
17. Feray C, Gigou M, Samuel D, et al. The course of hepatitis C virus infection after liver transplantation. Hepatology 1994; 20: 1137.
18. Marzano A, Smedile A, Abate M, et al. Hepatitis type C after orthotopic liver transplantation: reinfection and disease recurrence. J Hepatol 1994; 21: 961.
19. Johnson MW, Washburn WK, Freeman RB, et al. Hepatitis C viral infection in liver transplantation. Arch Surg 1996; 131: 284.
20. Rosen H, O'Reilly PM, Shackleton CR, et al. Graft loss following liver transplantation in patients with chronic hepatitis C. Transplantation 1996; 62: 1773.
21. Gane EJ, Portmann BC, Naoumov NV, et al. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 1996; 334: 815.
22. Fishman JA, Rubin RH, Koziel MJ, et al. Hepatitis C virus and organ transplantation. Transplantation 1996; 62: 147.
23. Olthoff KM, Millis M, Rosove MH, et al. Is liver transplantation justified for the treatment of hepatic malignancies? Arch Surg 1990; 125: 1261.
24. O'Grady JG, Polson RJ, Rolles K, et al. Liver transplantation for malignant disease. Ann Surg 1988; 207: 373.
25. Stone MJ, Klintmalm GB, Polter D, et al. Neoadjuvant chemotherapy and liver transplantation for hepatocellular carcinoma: a pilot study. Gastroenterology 1993; 104: 196.
26. Goldstein RM, Stone M, Tillery GW, et al. Is liver transplantation indicated for cholangiocarcinoma? Am J Surg 1993; 166: 768.
27. Dec GW, Kondo N, Farrell ML, et al. Cardiovascular complications following liver transplantation. Clin Transplant 1995; 9: 463.
28. Abbasoglu O, Levy MF. Cardiovascular events following liver transplantation. New Dev Transplant Med 1995; 2: 9.
29. Stegall MD, Everson G, Schroter G, et al. Metabolic complications after liver transplantation. Transplantation 1995; 60: 1056.
30. Navasa M, Bustamante J, Marroni C, et al. Diabetes mellitus after liver transplantation: prevalence and predictive factors. J Hepatol 1996; 25: 64.
31. Kibbler CC. Infections in liver transplantation: risk factors and strategies for prevention. J Hosp Infect 1995; 30(suppl): 209.
32. Munoz SJ. Long-term management of the liver transplant recipient. Med Clin North Am 1996; 80: 1103.
33. Dominguez EA. Long-term infectious complications of liver transplantation. Semin Liver Dis 1995; 15: 133.
34. Wajszczuk CP, Dummer JS, Ho M, et al. Fungal infections in liver transplant recipients. Transplantation 1985; 40: 347.
35. Paya CV, Wiesner RH, Hermans PE, et al. Risk factors for cytomegalovirus and severe bacterial infections following liver transplantation: a prospective multivariate time-dependent analysis. J Hepatol 1993; 18: 185.
36. Pirsch J, Kalayoglu M, Hafez GR, et al. Evidence that vanishing bile duct syndrome is vanishing. Transplantation 1990; 49: 1015.
37. The European FK506 Multicentre Liver Study Group. Reduced incidence of acute, refractory acute, and chronic rejection after liver transplantation with FK506-based immunosuppression. Transplant Proc 1994; 26: 3260.
38. Porayko MK, Kondo M, Steers JL, et al. Liver transplantation: late complications of the biliary tract and their management. Semin Liver Dis 1995; 15: 139.
39. Greif F, Bronsther OL, Van Thiel DH, et al. The incidence, timing and management of biliary tract complications after orthotopic liver transplantation. Ann Surg 1994; 219: 40.
40. Popescu I, Sheiner P, Mor E, et al. Biliary complications in 400 cases of liver transplantation. Mt Sinai J Med 1994; 61: 57.
41. Colonna JO, Shaked A, Gomes AS. Biliary strictures complicating liver transplantation incidence, pathogenesis, management, and outcome. Ann Surg 1992; 216: 344.
42. Morrison VA, Dunn DL, Manivel JC, et al. Clinical characteristics of post-transplant lymphoproliferative disorders. Am J Med 1994; 97: 14.
43. Penn I. Occurrence of cancers in immunosuppressed organ transplant recipients. In: Cecka JM, Terasaki PI, eds. Clinical transplants 1994. Los Angeles: UCLA Tissue Typing Laboratory, 1994: 99.
44. Levy M, Backman L, Husberg B, et al. De novo malignancy following liver transplantation: a single-center study. Transplant Proc 1993; 25: 1397.
45. Tan-Shalby J, Tempero M. Malignancies after liver transplantation: a comparative review. Semin Liver Dis 1995; 15: 156.